利用有创肾动脉压力与流速测量估算人体肾小球内压力
该研究在34例接受肾或心动脉造影的患者中,于基线和肾内多巴胺输注(30 μg/kg)诱导的充血状态下进行血流动力学测量,拟合改良三元件Windkessel模型估算肾小球内压力(Pglom)。28例(82%)数据可分析,基线平均Pglom为48.0 mm Hg(SD=10.1),充血时血流增加88%而Pglom下降13.1 mm Hg,糖尿病、BMI和肾灌注压与基线Pglom正相关。结论提示该模型可基于近端肾动脉压力和流速测量整体估算人体肾小球压力及入球/出球阻力,为研究CKD血流动力学提供新方法。
要点
- 改良三元件Windkessel模型可基于肾动脉压力和流速估算人体Pglom。
- 充血状态下Pglom下降13.1 mm Hg,入球小动脉顺应性增加165%。
- 糖尿病、BMI和肾灌注压与基线Pglom独立正相关。
核心结论
- 基于近端肾动脉压力和流速测量构建的模型可整体估算人体肾小球压力及入球和出球阻力。
研究设计与样本
- 在34例接受肾或心动脉造影的患者中,于基线和肾内多巴胺输注(30 μg/kg)诱导的充血状态下进行血流动力学测量,并拟合改良三元件Windkessel模型。
主要发现
- 28例(82%)患者数据成功分析,中位年龄58岁(IQR 52-65),中位eGFR 95 ml/min per 1.73 m2(IQR 74-100,CKD-EPI公式),30%有微量白蛋白尿,32%有糖尿病。
- 模型显示基线平均Pglom为48.0 mm Hg(SD=10.1)。
- 充血时血流增加88%(95% CI 68%至111%),入球顺应性增加165%(95% CI 79%至294%),Pglom下降13.1 mm Hg(95% CI 10.0至16.3)。
- 多变量线性回归中,糖尿病(系数10.1;95% CI 5.1至15.1)、BMI(每kg/m2系数0.99;95% CI 0.38至1.59)和肾灌注压(每mm Hg系数0.42;95% CI 0.25至0.59)与基线Pglom显著正相关。
临床怎么用
- 该模型可作为研究工具,基于直接压力和流速测量评估CKD的血流动力学。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Glomerular hyperfiltration resulting from an elevated intraglomerular pressure (Pglom) is an important cause of CKD, but there is no feasible method to directly assess Pglom in humans. We developed a model to estimate Pglom in patients from combined renal arterial pressure and flow measurements. METHODS: We performed hemodynamic measurements in 34 patients undergoing renal or cardiac angiography under baseline conditions and during hyperemia induced by intrarenal dopamine infusion (30 μg/kg). For each participant during baseline and hyperemia, we fitted an adapted three-element Windkessel model that consisted of characteristic impedance, compliance, afferent resistance, and Pglom. RESULTS: We successfully analyzed data from 28 (82%) patients. Median age was 58 years (IQR, 52-65), median eGFR was 95 ml/min per 1.73 m2 (IQR, 74-100) using the CKD-EPI formula, 30% had microalbuminuria, and 32% had diabetes. The model showed a mean Pglom of 48.0 mm Hg (SD=10.1) at baseline. Under hyperemia, flow increased by 88% (95% CI, 68% to 111%). This resulted in a 165% (95% CI, 79% to 294%) increase in afferent compliance and a 13.1-mm Hg (95% CI, 10.0 to 16.3) decrease in Pglom. In multiple linear regression analysis, diabetes (coefficient, 10.1; 95% CI, 5.1 to 15.1), BMI (0.99 per kg/m2; 95% CI, 0.38 to 1.59), and renal perfusion pressure (0.42 per mm Hg; 95% CI, 0.25 to 0.59) were significantly positively associated with baseline Pglom. CONCLUSIONS: We constructed a model on the basis of proximal renal arterial pressure and flow velocity measurements that provides an overall estimate of glomerular pressure and afferent and efferent resistance in humans. The model provides a novel research technique to evaluate the hemodynamics of CKD on the basis of direct pressure and flow measurements. CLINICAL TRIAL REGISTRY NAME AND REGISTRATION NUMBER: Functional HEmodynamics in patients with and without Renal Artery stenosis (HERA), NL40795.018.12 at the Dutch national trial registry (toetsingonline.nl).
引用
- Collard D, van Brussel PM, van de Velde L, et al. Estimation of Intraglomerular Pressure Using Invasive Renal Arterial Pressure and Flow Velocity Measurements in Humans. J Am Soc Nephrol. 2020. PMID: 32546595. doi:10.1681/ASN.2019121272
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。